StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.20−0.03 (-13.13%)

Close on Nov 16, 2026Market cap $2.73MP/E –Yield –

VolitionRx operating margin

Operating margin is operating income as a percentage of revenue.

VolitionRx's operating margin for the twelve months ending Jun 30, 2026 was -790.2%. For fiscal 2025 it was -1258.5%, against -2190.9% the year before. The highest annual figure on record is -1258.5% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1258.5%+932.4
FY2024Dec 31, 2024-2190.9%+2450.9
FY2023Dec 31, 2023-4641.8%+5730.6
FY2022Dec 31, 2022-10372.4%+21096.6
FY2021Dec 31, 2021-31469.0%+126707.3
FY2020Dec 31, 2020-158176.2%−64336.0
FY2019Dec 31, 2019-93840.2%−53581.8
FY2014Dec 31, 2014-40258.4%−32830.3
FY2012Dec 31, 2012-7428.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1042.5%+506.1
Q1 FY2026Mar 31, 2026-543.0%+1698.1
Q4 FY2025Dec 31, 2025-1077.9%+1938.6
Q3 FY2025Sep 30, 2025-813.2%+423.6
Q2 FY2025Jun 30, 2025-1548.6%+217.6
Q1 FY2025Mar 31, 2025-2241.1%+2646.8
Q4 FY2024Dec 31, 2024-3016.5%+566.1
Q3 FY2024Sep 30, 2024-1236.8%+4000.8
Q2 FY2024Jun 30, 2024-1766.2%+2648.4
Q1 FY2024Mar 31, 2024-4887.9%+1149.8
Q4 FY2023Dec 31, 2023-3582.6%+3108.8
Q3 FY2023Sep 30, 2023-5237.6%+19195.3
Q2 FY2023Jun 30, 2023-4414.5%+15960.5
Q1 FY2023Mar 31, 2023-6037.7%+684.0
Q4 FY2022Dec 31, 2022-6691.4%+55001.1
Q3 FY2022Sep 30, 2022-24432.8%+5243.0
Q2 FY2022Jun 30, 2022-20375.0%+3435.2
Q1 FY2022Mar 31, 2022-6721.7%+17113.4
Q4 FY2021Dec 31, 2021-61692.6%+17789.4
Q3 FY2021Sep 30, 2021-29675.8%+753701.6
Q2 FY2021Jun 30, 2021-23810.3%+76543.6
Q1 FY2021Mar 31, 2021-23835.1%+1055557.9
Q4 FY2020Dec 31, 2020-79482.0%−55054.4
Q3 FY2020Sep 30, 2020-783377.4%–
Q2 FY2020Jun 30, 2020-100353.8%–
Q1 FY2020Mar 31, 2020-1079393.0%–
Q3 FY2019Sep 30, 2019-24427.6%–

More VolitionRx figures

See a number that looks wrong?